Literature DB >> 8950295

Autonomous control of expression of genes for insulin-like growth factors during the proliferation and differentiation of C2C12 mouse myoblasts in serum-free culture.

Y Yoshiko1, K Hirao, K Sakabe, K Seiki, J Takezawa, N Maeda.   

Abstract

The proliferation and differentiation of skeletal muscle cells in culture are usually controlled by serum components, and the differentiation can be induced by a reduction in the serum concentration. Insulin-like growth factors (IGFs) play a critical role in stimulating myoblast differentiation, and the expression of their genes is controlled by serum factors. We have found that C2C12 myoblasts are capable of proliferation and differentiation even in serum-free medium that does not contain peptide mitogens. During these processes in serum-free medium, the accumulation of mRNAs for IGFs in the cells was observed; and their levels increased with concomitant increases in creatine kinase activity and myotube formation and a decrease in DNA synthesis. Thus, the present results suggest that proliferation and differentiation of C2C12 cells are autonomously controlled and that the increase in the expression of the IGFs may be independent of exogenous components.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950295     DOI: 10.1016/s0024-3205(96)00547-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  An Adult Mouse Thyroid Side Population Cell Line that Exhibits Enriched Epithelial-Mesenchymal Transition.

Authors:  Tsubasa Murata; Manabu Iwadate; Yoshinori Takizawa; Masaaki Miyakoshi; Suguru Hayase; Wenjing Yang; Yan Cai; Shigetoshi Yokoyama; Kunio Nagashima; Yoshiyuki Wakabayashi; Jun Zhu; Shioko Kimura
Journal:  Thyroid       Date:  2017-02-17       Impact factor: 6.568

2.  Tceal5 and Tceal7 Function in C2C12 Myogenic Differentiation via Exosomes in Fetal Bovine Serum.

Authors:  Aika Sawada; Takuya Yamamoto; Takahiko Sato
Journal:  Int J Mol Sci       Date:  2022-02-12       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.